[Clinical and rheoencephalographical evaluation of prodectin in the treatment of cerebral arteriosclerosis].
The reported investigations were carried out in a group of patients with evidence of cerebral circulatory disturbances aged from 43 to 72 years treated with Prodectin for 5-7 weeks. The dynamics of the clinical manifestations and REG curves were analysed before and after treatment. REG investigations were done using a II type rheograph with Fc-M leads. The basic parameters of the REG waves and reaction to nitroglycerin were evaluated. The results of REG were compared with the results of similar investigations in an age-matched control group. In nearly half the patients a tendency was observed for REG tracing normalization wit clinical improvement. Most frequently shortening of the ascending part of the REG wave was observed.
D000328:Adult; D000368:Aged; D002219:Carbamates / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010992:Plethysmography, Impedance; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D002219:Carbamates; D011727:Pyridinolcarbamate
Kliniczna i reoencefalograficzna ocena działania prodectinu w miazdzycy naczyń mózgowych.